Table 2.
lncRNAs | Origin cells | Expression in HCC | Role in HCC | Ways for crosstalk | Function in macrophages and/or HCC cells | Reference |
---|---|---|---|---|---|---|
SNHG20 | macrophages | upregulated | oncogene | ND | induce macrophage M2 polarization by STAT6; promote HCC cell invasion and EMT progress, enhance the progression from NAFLD to HCC | 154, 155, 156, 157 |
uc.306 | macrophages | downregulated | suppressor | ND | induce macrophage M1 polarization by the Wnt/BTRC signaling | 158 |
lncRNA cox-2 | macrophages | ND | suppressor | ND | induce macrophage M1 polarization; inhibit HCC cell proliferation, invasion, and migration | 99,159 |
GAS5 | macrophages | downregulated | suppressor | ND | reduce macrophage M2 polarization by PTEN; inhibit HCC cell migration, invasion, and chemoresistance by miRNA/mRNA | 160, 161, 162, 163, 164 |
ELMO1-AS1 | macrophages | downregulated | suppressor | ND | inhibit HCC cell proliferation, migration, and invasion by ELMO1 | 158,165 |
CCAT1 | HCC cells | upregulated | oncogene | ND | induce macrophage infiltration by the Let-7/HMGA2 axis; promote HCC cell proliferation, migration, and invasion by many miRNA/mRNA axis | 166, 167, 168 |
H19 | HCC cells | upregulated | oncogene | ND | induce macrophage infiltration and M2 polarization by the miR-193b/MAPK1 axis; promote HCC cell growth, migration, invasion, radio-, or drug resistance by many miRNA/mRNA axis | 169, 170, 171 |
MALAT1 | HCC cells | upregulated | oncogene | ND | re-educate macrophages from M1 to M2 polarization; promote HCC cell proliferation, migration, chemotherapy, resistance, mitochondrial and glucose metabolism, inhibit cell apoptosis and autophagy by many miRNA/mRNA axis | 172, 173, 174, 175, 176 |
PCED1B-AS1 | HCC cells | upregulated | oncogene | exosomes | induce macrophage immunosuppression by the miR-194-5p/PD-L1/2 axis; promote HCC cell proliferation, decrease cell apoptosis by mTOR signaling | 177 |
TUC339 | HCC cells | upregulated | oncogene | exosomes | induce macrophage activation and M2 polarization; promote HCC cell cycle, proliferation, and adhesion | 105,178 |
DLX6-AS1 | HCC cells | upregulated | oncogene | exosomes | induce macrophage M2 polarization by miR140; promote HCC cell viability, invasion, migration, and EMT progress by many miRNA/mRNA axis | 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135;136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170;171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212 |
LINC00662 | HCC cells | upregulated | oncogene | soluble protein | induce macrophage M2 polarization by the AWNT3A/Wnt/β-catenin signaling; promote HCC cell proliferation and invasion by miR-15a/16/107/AWNT3A/Wnt/β-catenin signaling | 179,180 |
TP73-AS1 | HCC cells | upregulated | oncogene | cytokines | induce macrophage M2 polarization by TGF-β; promote HCC cell proliferation, survival, and radioresistance by many miRNA/mRNA axis, including the miR-539-MMP-8 axis | 181, 182, 183 |
PPIAP22 | HCC cells | upregulated | oncogene | chemokines | induce macrophage infiltration by CCL15 or CXCL12; promote HCC cell growth by the miR-197-3p/PPIA axis | 184 |
HOTAIR | HCC cells | upregulated | oncogene | chemokines | induce macrophage recruitment by CCL2; promote HCC cell aerobic glycolysis, drug resistance, and EMT progress by many miRNA/mRNA axis | 185, 186, 187, 188 |
GIHCG | HCC cells | upregulated | oncogene | ND | induce macrophage infiltration; promote HCC cell proliferation and metastasis by miR-200b/a/429 | 189,190 |
ND, not determined.